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Abstract
Background: It is estimated that 2% of the global childhood population is living with some form of mobility
impairment. Although footwear interventions are proposed to aid ambulation, there appears to be a paucity in the
understanding of the effects of therapeutic footwear. This review aims to explore the effectiveness of footwear as
an intervention for mobility impairment in children.
Methods: A systematic search of MEDLINE, CINAHL, PubMed, SPORTdiscus and Scopus databases were
performed. Studies which focused on children with some form of mobility impairment, age of 9 months to
18 years, therapeutic footwear that allowed walking, and outcome measures that had explored biomechanical
or skeletal geometry or psychosocial aspects were included in this review. Modified Downs and Black quality
assessment index of randomised and non-randomised studies were used to assess the methodologies of
included papers.
Results: Out of 5003 articles sourced, 13 met the inclusion criteria for this review. These were grouped into
two titled “corrective and “functional” based on the types of footwear used for intervention. Studies within
the corrective footwear group included participants aged 11 months to 5 years with moderate congenital
talipes equino varus or mobile pes planus. While using skeletal geometry as an outcome, there was a limited
fair quality (level II) evidence that corrective footwear has no significant effect on the development of pes
planus but may assist in the reduction of deformity in congenital talipes equino varus. The functional
footwear group included participants aged 3 to 17 years, predominantly with mobile pes planus or cerebral
palsy. Based on biomechanical measures as an outcome, there was a limited fair quality (level III) evidence
that functional footwear alters biomechanical parameters in mobile pes planus (spatiotemporal) and cerebral
palsy (spatiotemporal, kinematic). Although psychosocial outcomes were considered within two studies, the
analysis was limited.
Conclusion: Only a limited number of studies have explored the effects of therapeutic footwear and only in
a narrow range of mobility impairments. Further high-quality research is required to improve the evidence
base for the effectiveness of therapeutic footwear. This should include a wide range of mobility impairments
and should focus both on physical and psychosocial outcomes.
Keywords: Shoes, Orthotic Devices, Disability, Child, Adolescent, Paediatric, Mobility Limitation, Assistive
Devices
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Background
Mobility impairment in children consists of a range of
congenital or acquired conditions that may be neuro-
logical, musculoskeletal or combined in nature, repre-
senting a spectrum of moderate to severe disability [1].
Mobility impairment affects the body structure and
function of a child which may lead to considerable social
and health detriments [1–3]. Around 2% of the child-
hood population is estimated to be living with some
form of mobility impairment [1–5] with a number of
these conditions requiring supportive intervention to aid
ambulation [6, 7].
Footwear is used as an intervention to aid ambulation in
mobility-impaired children [6–10]. Footwear intended for
therapeutic purposes in children consists of a broad range
of designs and clinical applications including pes planus,
talipes equino varus, toe walking, cerebral palsy and devel-
opmental delay [9, 11–16]. Footwear appears to be widely
prescribed as an assistive device by some healthcare pro-
fessionals [17], and a number of studies demonstrate that
conventional footwear has significant effects on typically
developing children’s gait [18, 19]. However, in contrast to
other assistive aids such as ankle-foot orthoses which have
seen an increase in research [20–23], there appears to be a
lack of understanding on the design, effects and purpose
of therapeutic footwear on children living with a mobility
impairment [24–26].
A recent scoping review by the authors [24]
highlighted that children’s footwear research has shown
a rapid increase in the past 10 years. However, footwear
intended for therapeutic purposes was represented in
just a small proportion of the recent literature, with lim-
ited empirical work and no focused review exploring its
effects in comparison to that of conventional children’s
footwear. There was also no precise terminology to de-
fine therapeutic footwear and the specifics of its role in
children living with mobility impairment. The scoping
review suggested that the term children’s therapeutic
footwear be used as the standard definition for footwear
that is designed specifically with the purpose to support
or alleviate mobility impairment in childhood. Further to
this, subgroupings of therapeutic footwear were sug-
gested dependent on the intended therapeutic role:
Corrective (footwear designed to bring about the cor-
rection of congenital skeletal lower limb alignment);
Accommodative (footwear designed to reduce com-
pression and shearing stresses on children’s foot de-
formities through the dimensional matching of
footwear to the child’s foot); and Functional (footwear
designed to improve dynamic gait parameters of chil-
dren with mobility impairment). In addition, the scop-
ing review highlighted the need for a systematic
assessment of the level and quality of evidence of
children’s therapeutic footwear research.
The overall aim of the systematic review is to establish
the effectiveness of therapeutic footwear in the treat-
ment of mobility impairment in children.
The objectives are to:
1. systematically search the published literature to
identify studies that have explored the physical or
psychosocial effects of therapeutic footwear on
children with mobility impairment.
2. establish the levels of evidence and quality of
evidence of the available research literature
concerning children’s therapeutic footwear.
3. explore the benefits and/or adverse effects of
therapeutic footwear interventions.
Methodology
The systematic review followed the PRISMA guidelines
[27]. Consideration was also given to recommendations
for conducting systematic reviews on paediatric partici-
pants [28, 29]. The protocol for the review was regis-
tered with PROSPERO: International prospective
register of systematic reviews (CRD42018097038) [30].
Searches
A search strategy using medical subject headings (MeSH)
and free-text terms related to children and footwear were
developed. Databases used in this search were MEDLINE,
PubMed, CINAHL, SCOPUS, and Sportdiscus. An ex-
ample of the search strategy can be found in Additional
file 1. The search strategy was adapted across the data-
bases to capture eligible articles published from database
inception to February 1st, 2018.
Eligibility of studies
Study designs considered for this review included rando-
mised control trials (RCTs), non-randomised controlled
trials, experimental before-after studies, prospective and
retrospective comparative cohort studies, and case-
control studies. Case series and case report studies were
not considered for inclusion. All articles to be available
in full English language text.
Participants in the included studies were infants, chil-
dren and adolescents of typical walking and shod age (9
months to 18 years of age) with some form of mobility
impairment (defined as a musculoskeletal or neuro-
logical condition that affects motor performance). Indi-
viduals must be able to ambulate independently or with
an assistive device (e.g., arm or underarm crutches,
walking frames).
Interventions included the provision of therapeutic
footwear to children with a mobility impairment that fa-
cilitates and allows ambulation. Studies were included
where therapeutic footwear was provided and assessed
separately as an independent variable.
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Therapeutic footwear that did not permit ambulation
during wear (e.g., nocturnal braced footwear) were ex-
cluded. Comparators included studies that compare
therapeutic footwear to barefoot, standard retail foot-
wear, orthotic interventions and different types of thera-
peutic footwear.
Primary outcomes considered biomechanical and skel-
etal geometric measures assessing the effects of thera-
peutic footwear on lower limb development and
function. Secondary outcomes considered measures
assessing the effect of therapeutic footwear on children’s
quality of life, including, physical activity, societal par-
ticipation, self-esteem, and pain. Reports of adverse ef-
fects (e.g. footwear fit related pain/discomfort) in the
included studies were also considered.
Study selection
Prior to screening, all duplicates were removed using
referencing software (Mendeley, Elsevier BV) and sup-
plemented by a manual check by one reviewer (MH).
Screening followed on from the previous scoping review
[24], where one reviewer (MH) had independently iden-
tified studies that considered children’s footwear from a
therapeutic perspective amongst the total records
sourced. These abstracts were then screened by two re-
viewers (MH, AH) against the eligibility criteria of the
systematic review with any uncertainty resolved through
discussion with the third reviewer (NC). Full texts were
located for all studies that appeared to meet the inclu-
sion criteria and those studies where there was uncer-
tainty regarding eligibility.
Two reviewers (MH and AH) independently screened
the full-text articles to assess whether these met the eli-
gibility criteria. Any disagreements regarding study eligi-
bility between the reviewers were resolved through
mediation with a third reviewer (NC).
Data extraction
A data extraction form was developed, and information
relevant to the review question was extracted from the
included studies [31]. These included author names, date
of publication, study design, participant characteristics
(number of participants, age, sex, height, mass), descrip-
tion of intervention and comparison, experimental
methodology, duration of follow-up, primary and sec-
ondary outcomes, adverse events and key results. Data
were extracted by one reviewer (MH). The extracted
data were checked for correctness and completeness
against the full-text articles by a second reviewer (AH).
Levels of evidence and quality assessment
The levels of evidence of each included study were
assessed by two reviewers (MH and AH) using the
Oxford Centre for Evidence-Based Medicine level of
evidence version 2 (OCEBM) [32]. The quality of the
studies was assessed independently by two reviewers
(MH and AH). Quality assessment was completed using
the modified Downs and Black quality assessment index
(QI) of randomised and non-randomised studies [33,
34], which has been used in previous systematic reviews
of footwear and orthoses [18, 35]. Questions that were
not applicable to the study under assessment were not
applied (i.e. non-longitudinal studies, studies with only
one testing group). Scores were therefore adjusted to an
overall percentage to mitigate for the differing total
scores. In line with Trac et al. (2016) [34] the percentage
scores were grouped into the following four QI levels:
excellent (92 to 100%), good (71 to 91%), fair (50 to
70%), and poor (less than 50%). Survey studies were
assessed separately using the tool suggested by Burns
and Kho [36]; this was carried out independently by two
reviewers (MH and AH).
Outcome measures from individual trials with accept-
able levels of homogeneity in participant characteristics
and experimental protocols were planned to be com-
bined through meta-analysis. Where a meta-analysis was
not possible, the results from clinically comparable trials
were synthesised qualitatively. Data was grouped primar-
ily on therapeutic footwear classification established in
the previous scoping review [24], with subgrouping of
the included studies dependent on the type of outcomes
measures (biomechanical, skeletal geometry, quality of
life), and pathology/medical condition.
Results
Database searches yielded 5003 unique articles (Fig. 1) with
3 further papers found through screening the reference lists
of related reviews sourced from the previous scoping review
[24]. From these, 80 articles were identified as discussing
children’s therapeutic footwear with 23 articles identified
for full-text eligibility screening. Thirteen studies met the
eligibility criteria for inclusion. A summary of the findings
is presented in Tables 1, 2, 3, 4, 5 with supplementary re-
sults found in Additional files 2 and 3. Details of the levels
of evidence and quality assessment of the included studies
are provided in Additional files 4 and 5. None of the studies
offered an acceptable level of homogeneity to allow
the data to be combined for meta-analysis. This was
due to a number of factors including, lack of suffi-
cient detail to assure similar footwear design between
studies, and incomplete description of the partici-
pants’ characteristics (Table 1 and 2). These issues
precluded a combined analysis even for those studies
with the same footwear grouping, clinical condition
and outcomes [12, 37]; therefore, only a qualitative
analysis of the included studies was possible.
Analysis and synthesis of the studies were performed
according to the grouping/subgrouping of footwear
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interventions, with further subdivision by the medical
condition of the study participants (see Table 1).
Therapeutic footwear interventions
The types of therapeutic footwear interventions that
were explored in the 13 studies fell into 2 of the previ-
ously defined groupings from the scoping review [24]
corrective (n=3) and functional (n=10) (Table 1). No
studies explored the effects of accommodative thera-
peutic footwear for children. None of the included stud-
ies reported adverse events or stated if such events were
considered within the study plan.
Corrective Footwear
These three studies focused on the effects of the foot-
wear on lower limb alignment pes planus (n=2) [12, 37]
and congenital talipes equino varus (CTEV) (n=1 )[16]
(Table 1). The studies were all randomised controlled
trials (level II evidence). Two of the studies were of fair
QI [16, 37] and one of poor QI [12]. A total of 196 chil-
dren were examined across the studies with an age range
from 11 months to 5 years (Table 1, Additional file 2).
One study failed to report the sex distribution amongst
the experimental groups [12], and the height and mass
of the participants were only reported in one study [16].
Two of the studies [16, 37] had sufficient sample size to
detect a medium effect size of 0.3 at 0.05 significance
and 80% power [45]. However, one of the studies suf-
fered a loss to follow up >20% [37] with no intention to
treat factored into the analysis.
Various design characteristics were reported for the
corrective footwear (Table 2) in the three studies. Con-
sistent features appeared to be some form of reinforced
or lengthened heel counter or arch inlay [12, 16, 37].
The common comparator to corrective footwear inter-
ventions across all three studies was daily wear of stand-
ard retail footwear (see Table 1). One study also
considered orthotic arch support or heel cups [37].
Fig. 1 PRISMA flow diagram
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Assessors were blinded in only one of the three studies
[37]. Primary outcomes focused on skeletal geometric
measures which were presented in the three studies in-
cluded in this grouping (Table 3). These were radio-
graphic measures of the skeletal alignment of the foot in
two studies considering pes planus [12, 37], and 3D
scanned images of the foot and ankle for the study con-
sidering CTEV [16]. Only one study in this grouping
[16] considered biomechanical outcomes (Table 4) con-
sisting of pressure ratios of the heel to forefoot and heel
to lateral midfoot in walking conditions. Secondary out-
comes, as determined by this current review, were not
reported in any study amongst the corrective footwear
grouping. Results indicated that there was no statisti-
cally significant effect of corrective footwear versus read-
ily available retail footwear in the developmental of
asymptomatic paediatric pes planus. Daily wear of cor-
rective footwear in combination with nocturnal wear of
Dennis Brown splint did not appear to offer any differ-
ence to the 3D scans of the trans-malleolar axis, and the
bean-shaped ratio of CTEV in comparison to daily wear
of standard footwear and nocturnal wear of Dennis
Brown splint [16]. However, the study did demonstrate
statistically significant improvements in 4 of the 13
plantar pressure measures (Table 4) indicating a reduc-
tion of equinus and varus deformity with the daily wear
of corrective footwear and nocturnal use of Dennis
Brown splint. Results for the nine plantar pressure mea-
sures that were not statistically significant concerning
CTEV and corrective footwear, but highlighted the ef-
fects of different nocturnal splints, can be found in Add-
itional file 3.
Functional Footwear
Functional footwear intervention studies focused chiefly
on biomechanical primary outcomes (kinematic, kinetic,
spatiotemporal, balance) (Table 4, Additional file 3) which
were considered in 7 of the 10 studies [10, 11, 14, 40–43].
Skeletal geometry primary outcomes (Table 3) were con-
sidered in only two of the studies [39, 44]. Secondary out-
comes were considered in two studies [38, 39] but
empirically reported in one [38] (Table 5). A total of 311
children were considered amongst the studies with an age
range from 3 to 17 years (Table 1, Additional file 2).
Reporting of the participants’ height and mass was pro-
vided in four studies [10, 11, 14, 43] (Table 1). It was
noted that the small sample size affected the statistical
power in all but two of the experimental studies amongst
Table 2 Description of footwear interventions in included studies.
Study Description provided of therapeutic footwear intervention (s)
Corrective Therapeutic Footwear
Chen et al (2015) [16] Orthopaedic shoe with an orthopaedic insole and hard heel cup (CTF)
Kanatli et al (2016) [12] Custom made orthopaedic shoe, 0.5-0.9cm longitudinal arch support, 3-4mm heel wedges. (CTF)
Wenger et al (1989) [37] Orthopaedic shoe, steel shank, Thomas heel, long medial heel counter, navicular pad (CTF)
Functional Therapeutic Footwear
Functional Stability
Abd Elkader et al (2013) [14] Medical shoes same brand and model (brand/model not stated) with prefabricated arch insert (FSTF)
Aboutorabi et al (2014) [11] Custom made, High-top shoes, wide toe box, internal heel counter, arch inlay (FSTF)
Bakker et al (1997) [38] No details other than off the shelf orthopaedic footwear (FSTF)
Basta et al (1977) [39] High topped, Steel Shank, firm counter (FSTF)
Jagadamma et al (2009) [40] Custom made heel to forefoot wedged EVA sole adhesion, used alongside AFO. Wedges adjusted
until shank to vertical angle reached 12°. (FSTF+AFO)
Knittel and Staheli (1976) [41] Low cut shoe with 9 various sole modifications, medial forefoot wedge only (FSTF 1), lateral forefoot
wedge only (FSTF 2), medial forefoot and medial rearfoot wedge
(FSTF 3), lateral forefoot and medial rearfoot wedge (FSTF 4), lateral forefoot and lateral rearfoot wedge
(FSTF 5), medial rearfoot wedge only (FSTF 6), lateral rearfoot wedge only (FSTF 7), parallel torqheel
(FSTF 8), circular torqheel (FSTF 9).
Wesdock & Edge (2003) [42] Custom made Styrofoam wedged sole adhesion, wedge = vertical distance of posterior inferior elevated
heel of the unaltered shoe from the floor when subject with crouch gait stood as erect as possible. (FSTF+AFO)
Functional Instability
Ramstrand et al (2008) [43] Masai Barefoot Technologies, MBT unstable sole shoe. (FITF)
Functional Lift
Eek et al (2017) [10] 12 mm EVA sole adhesion divided into two parts heel and forefoot, (FLTF)
Zabjek et al (2001) [44] Various sole lift adhesion 5mm, 10mm,15mm, (FLTF)
AFO Ankle Foot Orthosis, CTF Correctional therapeutic footwear, FSTF Functional stability therapeutic footwear, FITF Functional instability therapeutic footwear,
FLTF Functional lift therapeutic footwear
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the functional footwear grouping studies [11, 46]. None of
the studies blinded the participants to the intervention,
with only one study blinding the assessor [14]. Sufficient
information on the participant recruitment strategy was
provided in only two studies [10, 38]. Three of the studies
stipulated a brief wearing in period to allow the child to
become accustomed to walking in the interventions [10,
11, 14]. Functional footwear was split into three design
characteristic subgroups: Stability, Instability, and Lift as
defined by the previous scoping review [24].
Stability footwear There were seven studies in this sub-
grouping with various footwear designs used amongst
the studies (Table 2). Five studies involved footwear of-
fering some form of medial-lateral stability with arch in-
lay and/or reinforced heel counte r[11, 14, 38, 39, 41]
and two studies involved footwear with anterior-
posterior sole wedging that work alongside Ankle Foot
Orthoses (AFO) to offer sagittal stability [40, 42]
In relation to footwear that offered mediolateral stabil-
ity, the study designs consisted of four before-after stud-
ies (level III evidence) [11, 14, 39, 41] and one survey
study (level IV evidence) [38]. Two of these studies were
of fair QI [11, 14] and two poor QI [39, 41]. The survey
study met 64% of the survey quality criteria [38]. The
medical conditions of the participants were mobile pes
planus, Down’s syndrome, in-toeing and Duchenne
muscular-dystrophy (Table 1) [11, 14, 38, 39, 41]. Vari-
ous comparators were considered (Table 1). Barefoot
conditions, walking or stance, was the baseline assess-
ment in three of the five studies [11, 14, 39]. Standard
unmodified footwear was considered in three of the
studies [38, 39, 41]. Arch inlays/foot orthosis was a com-
parator either fitted to stability footwear in one paper
[39] or to standard footwear in another paper [11].
AFOs, Knee Ankle Foot Orthoses (KAFO), and standing
frames were additionally considered in one study [38].
Medical taping was a consideration in one study [14].
Stability footwear with various sole modifications were
compared in one study [41].
Primary outcomes considered both biomechanical
(Table 4) and skeletal geometric measures (Table 3).
One study demonstrated statistically significant changes
in spatiotemporal parameters (increase in velocity and
stride length, reduction in the base of support) in chil-
dren with Down’s syndrome whilst wearing stability
footwear compared to the barefoot condition [14]. How-
ever, no differences were noted between the stability
footwear group and the taping comparator group in this
study [14]. One study demonstrated a statistically signifi-
cant reduction in the centre of pressure (CoP) displace-
ment and increased step velocity in the stability footwear
compared to the barefoot condition for individuals with
pes planus [20]. No statistically significant difference was
found in step symmetry in this study between barefoot
and stability footwear conditions. However, the regular
shoe with orthosis demonstrated a statistically significant
increase in step symmetry compared to stability footwear
conditions [11]. Mediolateral wedged sole modifications
were shown to have no statistically significant effect on in-
toed angle of gait. Torqheels (circular sole additions that
impart a torque on ground contact [47]) did show a statis-
tically significant reduction of the in-toed angle of gait
(approximately 33%) compared to a standard soled foot-
wear [41]. Skeletal geometry outcomes used were immedi-
ate weight-bearing radiographic alignment changes to the
medial longitudinal arch in participants with symptomatic
pes planus. Skeletal alignment was seen to improve in sta-
bility footwear vs. barefoot conditions [39]. However, no
statistical analysis was performed on these effects. Add-
itionally, there was absent reporting of the changes to
these angles in standard footwear conditions [39].
Secondary outcomes, as outlined by this review, were
explored in two of the mediolateral stability footwear
studies. Reduction of foot fatigue and pain in pes planus
were investigated in one paper [39]. This paper demon-
strated these outcomes improved for the stability foot-
wear intervention compared to standard footwear and
arch inlay. However, no statistical analysis was per-
formed on these findings. The second paper considered
surveying parents of children with Duchenne’s muscular
dystrophy (DMD) as to the reluctance to use the pre-
scribed assistive device and pain whilst using the device
[38] (Table 5). This demonstrated that stability footwear
was associated with less reluctance to wear and less pain
experienced compared to AFOs, KAFOs and standing
frames. This study failed to provide information on the
design or testing of the questionnaire. Additionally, there
was no statistical analysis performed, and it was unclear
as to the severity of the DMD amongst the different in-
terventions or if the pain measured was from the device
or from the condition itself.
In relation to footwear that offered sagittal stability,
study design consisted of one before-after design [40]
and one cross over study [42]; both studies were of fair
QI. The medical conditions of the participants consisted
of spastic cerebral palsy with knee hyperextension [40]
or crouch gait [42] (Table 1). Comparators consisted of
standard footwear in one study [42] and AFO worn with
standard footwear combination in both studies [40, 42]
(Table 1). Biomechanical outcomes were considered in
both these studies [40, 42] (Table 4). One study demon-
strated a statistically significant improvement on knee
hyperextension and shank to vertical angle (SVA) kine-
matics in sagittal wedged soled footwear in combination
with AFO compared to the standard sole footwear with
AFO [40]. However, no kinetic or spatiotemporal vari-
able reached statistical significance [40]. Standing
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balance was considered in the second study. This study
found statistically significant improvement for differ-
ences in standing balance in a sub-set analysis of diplegic
individuals with Gross Motor Function Scores (GMFS)
2-3 for AFOs and anteroposterior sagittal wedged foot-
wear combination intervention compared to both stand-
ard footwear and AFO standard footwear combination
[42].
Instability footwear This subgrouping consisted of one
study that considered commercially available MBT® foot-
wear [43]. This footwear consists of a rounded sole shoe
with a midfoot pivot [43] (Table 2). The study was a
before-after design (level III evidence) of poor QI. The
health conditions considered were highly varied in the
group and consisted of cerebral palsy, Prader Willi, un-
specified motor and development delay, Cornelia de
Lange syndrome and Attention Deficit Hyperactive Dis-
order (ADHD) (Table 1). The grading and degree of the
mobility impairments of the participants were not fully
described. All individuals wore the MBT footwear for
the 8-week period and were tested barefoot and in the
MBT footwear (Table 1 and 4). Biomechanical outcomes
of static and dynamic balance were considered in this
study (Table 4). No spatiotemporal kinematic or kinetic
outcomes were considered. This footwear did not dem-
onstrate any statistically significant effects on static bal-
ance and a number of dynamic balance outcomes; these
results are presented in Additional file 3. However, two
of the dynamic balance outcomes were seen to statisti-
cally significantly improve, with a reduction in the num-
ber of falls seen over the course of the study and
improvement in the mediolateral control of the centre of
pressure displacement. It must be noted that two of the
participants were unavailable for the four-week testing
point and one other participant failed to understand the
instructions for the control aspect of dynamic balance
testing. Intention to treat analysis was not reported to
account for this drop off in participation.
Lift footwear Lift footwear was described as consisting
of unilateral outer-sole adhesions (Table 2) [10, 44]. This
subgroup consisted of two before and after studies; one
fair QI [10] and one poor QI [44]. Poor reporting of the
intervention and the participants affected the QI of one
study [44]. Conditions considered were limb length in-
equality in combination with either, idiopathic scoliosis
[44] or spastic cerebral palsy [10] (Table 1). Barefoot
conditions, walking or stance, was considered as a com-
parator in both studies [10, 44], with standard sole foot-
wear also considered in one study [10] (Table 1).
Spatiotemporal and kinematic variables were considered
in individuals with spastic cerebral palsy and limb length
inequality, in one of the studies [10] (Table 4). Statisti-
cally significant differences seen between stance time in
the long and short leg in barefoot and unmodified shod
conditions were not seen in the lifted footwear interven-
tion. Velocity was also statistically significantly increased
in the lifted footwear compared to the barefoot condi-
tions. Statistically significant kinematic differences be-
tween hip flexion at initial contact and swing and ankle
dorsiflexion in stance seen between the long and short
limb in the barefoot condition were no longer significant
in the lifted footwear condition. The second study con-
sidered skeletal geometric measures of acute changes on,
lower limb, pelvic, and spinal posture through radio-
graphs and 3D marker system of first barefoot, then
lifted sole conditions [44] (Table 3). Sole lifted condi-
tions statistically significantly reduced the Cobb angle,
pelvic tilt, version between right and left iliac bones, and
shoulder tilt compared to barefoot conditions. These
Table 5 Secondary outcome measures
Outcome Study Condition Group Baseline Mean (SD ±/-) Finala Mean (SD +/-)
Functional Stability Therapeutic Footwear
Pain whilst using device Bakker et al. (1997) [38] DMD FSTF N/A 1.42 (0.53)
1=no pain Own footwear N/A 1.02(0.51)
KAFO N/A 3.0 (1.87)
5=great deal of pain SF N/A 2.33 (1.03)
AFO N/A 2.20 (1.39)
Reluctance to use device FSTF N/A 2.28 (1.25)
1=not reluctant Own footwear N/A 1.29 (1.35)
KAFO N/A 3.0 (1.58)
5=great deal of reluctance SF N/A 3.66 (1.21)
AFO N/A 2.85 (1.53)
AFO Ankle Foot Orthosis, DMD Duchenne Muscular Dystrophy, FSTF Functional Stability Therapeutic Footwear, KAFO Knee Ankle Foot Orthosis, N/A Not Applicable,
SF Standing Frame, aNo statistical test for significance performed
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findings are thought to demonstrate acute improvements
in idiopathic scoliosis posture.
Discussion
The review identified 13 empirical studies that explored
the effects of therapeutic footwear in children with mo-
bility impairment. Study quality was negatively affected
in most studies by the reporting strategy, with a lack of
descriptions of basic participant anthropometrics and in-
adequate blinding of participants and assessors impact-
ing on generalisability and internal and external validity.
Another consideration that may impact on long term
conservative footwear management is compliance with
the intervention [48]; this was not accounted for or was
inconsistently measured in the studies potentially intro-
ducing confounding bias [49, 50].
The medical conditions with the highest number of
studies were pes planus (five studies) and cerebral palsy
(four studies). It must be noted three studies, consider-
ing pes planus appeared to only acknowledge the pos-
tural presentation with no apparent symptoms or other
underlying pathology identified [11, 12, 37]. Therapeutic
interventional studies should consider expanding on the
descriptors of inclusion for pes planus in children [51–
53] to avoid the possibility of medicalising healthy
physiological development [54] and potential detriment
to the health economy and the individual [55, 56]. The
effects of footwear as a therapeutic intervention on other
noteworthy conditions that impact on children’s mobility
such as joint hypermobility syndrome [57], spina bifida
[58], developmental coordination disorder [59], juvenile
idiopathic arthritis [60], and Charcot Marie Tooth [61]
were not considered in the included studies.
The age of the participants showed distinct differences
between the two main footwear groupings with correct-
ive footwear considering a younger age range (11
months to 5 years) and functional footwear a broader
age range (3 to 15 years) (Additional file 2). This may be
explained by the increased percentage of cartilage in the
infant skeleton having the perceived potential to be in-
fluenced by conservative intervention [62, 63] in relation
to corrective footwear, and the broader age range in
functional footwear linked to the ongoing need for as-
sistive aid for children with mobility issues in daily activ-
ity. Primary outcomes were focused towards skeletal
geometry in all of the corrective footwear studies as
would be expected since the aim of treatment is to bring
about realignment of the skeletal system in the lower
limb [24]. Primary outcomes for functional footwear
were focused on biomechanical variables in 7 out of the
10 studies. This again would be expected since the pur-
pose of functional footwear is to assist children’s gait pa-
rameters [24].
In consideration of corrective footwear grouping, the
studies explored their effects for asymptomatic flexible
pes planus and CTEV alongside nocturnal barred foot-
wear post serial casting. One fair quality study, for a
relatively large sample size, would suggest that corrective
footwear offers no effect on mobile asymptomatic pes
planus in children [37]. One fair quality controlled group
study [16] suggests daily use of corrective footwear
alongside nocturnal splinted footwear can improve the
equinus and varus positioning of the forefoot. However,
caution must be observed as CTEV is a heterogeneous
pathology [64], and this study failed to report the aetiol-
ogies of the participants’ deformities, thus affecting the
generalisability of the study’s findings.
The studies across the subgroupings of functional
footwear were mainly experimental before and after de-
sign and one survey (Additional file 4 and 5). The sig-
nificance of the changes observed in these studies could
have been a short term effect [65] due to an insufficient
wearing in and accommodation period. A learning effect
could also impact on the findings [66] with participants
able to anticipate factors such as those that required dy-
namic balance [43]. Further research with suitable wear-
ing in periods and a control group study design would
be beneficial to corroborate the findings of these studies.
Stability footwear was seen to comprise of two general
designs; one to assist mediolateral stability [11, 14] and
one to work alongside AFOs to assist sagittal stability
[40, 42]. For mediolateral stability design, one fair quality
study demonstrated statistically significant effects on vel-
ocity and mediolateral CoP displacement in children
with pes planus between stability footwear intervention
and barefoot [11] with one further fair quality study
demonstrating statistically significant effects on velocity,
stride length, and base of support for stability footwear
vs. barefoot conditions in individuals with Down’s syn-
drome [14]. However, both the studies did not compare
these effects with a standard children’s footwear condi-
tion that has also demonstrated statistically significant
effects on spatiotemporal measures in children com-
pared to barefoot conditions [18]. This opens the signifi-
cance of the spatiotemporal findings for this footwear to
debate and precludes any recommendations advocating
this intervention over standard footwear in clinical prac-
tice for children with flexible pes planus or Downs syn-
drome. There is poor quality evidence that sole
modification reduces the in-toed angle of gait by a third
compared to standard sole footwear; however, the need
to treat this developmental variant conservatively is de-
batable [67]. One survey indicated that stability footwear
was associated with less reluctance to use and less pain
than other assistive devices in individuals with DMD.
However, the severity of the condition amongst those
using the various devices was not stated; this precluded
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any informed clinical recommendation for the use of sta-
bility footwear in this condition. Those studies that con-
sidered sagittal stability demonstrated fair quality
evidence in two studies that this footwear combined
with a customised AFO can improve, knee and shank
vertical angle in spastic CP [40] or standing balance in
spastic diplegic GMFS 2-3 crouch gait [42]. Therefore
sagittal stability footwear could tentatively be recom-
mended over standard retail footwear for AFO footwear
combination in children with spastic CP. Evidence indi-
cated that instability footwear improves dynamic balance
(number of falls and control of mediolateral CoP dis-
placement) in a range of children’s developmental dis-
abilities. However, the quality of this study was poor,
with failure to account for dropout across the testing
period, and a diverse range of mobility impairments con-
sidered in the sample (Table 1) questioning the validity
of the central trend analysis obtained [43].
Lift footwear offered fair quality evidence in one study
to improve the symmetry of a wide range of kinematic
and spatiotemporal gait parameters between the long
and short limb in individuals with spastic cerebral palsy
potentially supporting its use for individuals with this
clinical presentation [10]. Spinal and pelvic skeletal
geometry were seen to improve in individuals with idio-
pathic scoliosis; however, this was of poor quality with
no standard footwear comparator and insufficient infor-
mation provided on the participants and recruitment
strategy opening the significance and generalisability of
the findings to debate [44].
It was noted that a number of studies amongst the
functional footwear grouping contained a degree of
heterogeneity in the participant’s age ranges and vari-
able motor impairment. There were over seven year
age ranges in some studies [40, 42, 43]; since devel-
opment affects biomechanical parameters [18, 68], this
should be considered when averaging biomechanical
outcome data. Further consideration should be given
to the studies that averaged biomechanical outcome
data amongst individuals with cerebral palsy [10, 40,
42] as this condition has a significant range of motor
impairment that may not be amenable to central
trend analysis [69–72].
There is relatively limited research concerning any
grouping of therapeutic footwear. Level of evidence
ranged from II to IV, but no study exceeded a quality as-
sessment of fair, due to methodology that affected both
internal and external validity. This entails a conservative
recommendation from the current evidence base con-
cerning clinical usage of therapeutic footwear. There ap-
pears to be evidence that corrective footwear is not
recommended as an intervention for developmental pes
planus since there is no apparent favourable outcome
compared to standard footwear in infants and young
children. With an unnecessary prescription of corrective
footwear leading to potential over-medicalisation of typ-
ical development and psychosocial detriment in early
adult life [54, 56]. Functional footwear appears to be
able to play a role in assisting children with mobility im-
pairment across a broader age range than corrective
footwear; however, these studies invariably suffer from a
small sample size potentially being underpowered to de-
tect any statistically significant effect. Future studies for
functional therapeutic footwear must consider a com-
parison with standard footwear, as suggested by Wege-
ner et al. [18], to factor in the effects of regular footwear
on children’s gait in comparison to barefoot conditions.
Further comparison to other assistive devices such as
foot orthoses is warranted in order to inform when sta-
bility footwear should be used as an alternative or in
combination with foot orthoses, and where lift therapy
for limb length inequality is best addressed with remov-
able inlays or external shoe modifications.
Other recommendations for general therapeutic foot-
wear research include clear reporting of participant
characteristics and the distribution of demographics be-
tween treatment groups, to include, sex, height and mass
which have demonstrated effects on foot function and
skeletal geometry in previous studies [73–75]. Consider-
ation of participant recruitment strategies is required;
being mindful of institutional bias in the samples se-
lected, and more transparent recruitment reporting to
inform on the external validity of the work [33]. The
lack of consideration of adverse events across the studies
warrants comment since it is imperative intervention
studies declare adverse events or the measures taken to
capture these, as appropriate evidence base should iden-
tify the potential harms as well as benefits of any thera-
peutic intervention [76].
The psychosocial impact of therapeutic intervention
is an important consideration for mobility-impaired
children [77]. The World Health Organisation’s inter-
national classification of function for children living
with disabilities considers a number of factors to en-
sure the child can achieve the highest quality of life
[2]. The current evidence base concerning therapeutic
footwear has chiefly focused on the body structure
and functional aspects of the ICF-CY but has not
attempted to assess the long-term or psychosocial ef-
fects the intervention may have on the child’s quality
of life in terms of the ability to participate in daily
activities or relief of pain.
Limitations of the current study
The initial screening of the studies that identified
children’s therapeutic footwear was performed inde-
pendently by the one author (MH) during the preced-
ing scoping review [24], which may have opened
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these processes to personal bias. The review has con-
sidered only those articles with an available English
language abstract which may have impacted on the
scope of research. Incomplete description of the
therapeutic footwear together with the lack of infor-
mation on basic anthropometrics (height, mass, BMI),
heterogeneity of the participants, and the broad range
of outcomes precluded a quantitative analysis of the
aggregated results which could be perceived as a limi-
tation. There were 76 different outcome measures
considered across the included studies with few
reporting on the same outcome measures. The defin-
ition and adoption by researchers to minimum sets of
condition-specific outcome measures, such as those
presented by the International Consortium for Health
Outcome Measurement (ICHOM) [78], will enable
between study comparisons and meta-analyses of fu-
ture research.
Conclusion
There are a limited number of studies exploring the ef-
fects of children’s therapeutic footwear; these have
mainly been studied on children with pes planus and
cerebral palsy. Limited fair quality level II evidence is
available that corrective footwear has no statistically sig-
nificant effect on apparent typical developmental pes
planus. Conversely, there is limited fair quality level II
evidence that it can offer a corrective effect in mild to
moderate cases of CTEV in infancy. Functional thera-
peutic footwear offers limited fair quality level III evi-
dence on apparent improvement to gait parameters in
pre-school and primary school-aged children with pes
planus, Down’s syndrome or CP. Included studies ex-
plored body structure and functional aspects of the
WHO ICF-CY (biomechanical and skeletal geometry
outcomes). However, psychosocial aspects of the ICF-CY
concerning the quality of life appears largely absent in
the research.
Review findings suggest that further research on thera-
peutic footwear with robust study designs is warranted.
The outcome measures should consider a full range of
ICF-CY aspects, and the reporting should include a clear
description of the footwear interventions, participant
characteristics, recruitment strategy and measures of ad-
verse events. These recommendations will improve the
current evidence base for therapeutic footwear as an
intervention for children with mobility impairment.
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